| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.102 | 21.027 | 25.025 | 21.788 | 19.925 | 24.264 | 31.064 | 32.819 | 31.002 | 37.021 |
| Total Income - EUR | 15.102 | 21.027 | 25.025 | 21.788 | 19.925 | 24.264 | 31.107 | 34.784 | 31.008 | 37.022 |
| Total Expenses - EUR | 2.798 | 3.281 | 4.466 | 9.180 | 3.356 | 5.369 | 12.495 | 13.852 | 22.430 | 23.573 |
| Gross Profit/Loss - EUR | 12.304 | 17.746 | 20.559 | 12.607 | 16.569 | 18.895 | 18.612 | 20.932 | 8.578 | 13.449 |
| Net Profit/Loss - EUR | 11.851 | 17.115 | 19.808 | 11.954 | 15.971 | 18.167 | 17.791 | 20.462 | 8.305 | 13.119 |
| Employees | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sanipid New Era Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.170 | 1.007 | 850 | 696 | 0 | 0 | 0 |
| Current Assets | 17.727 | 17.685 | 36.730 | 46.834 | 57.804 | 75.447 | 91.747 | 22.490 | 27.657 | 37.705 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 69 | 0 | 5.393 | 5.363 |
| Receivables | 16.827 | 8.754 | 8.217 | 8.044 | 54.334 | 73.006 | 86.467 | 17.276 | 19.501 | 23.513 |
| Cash | 899 | 8.931 | 28.514 | 38.789 | 3.471 | 2.441 | 5.212 | 5.214 | 2.762 | 8.828 |
| Shareholders Funds | 17.614 | 17.168 | 36.686 | 47.967 | 58.684 | 75.738 | 91.849 | 17.559 | 25.810 | 34.415 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 113 | 517 | 44 | 37 | 127 | 559 | 594 | 4.931 | 1.846 | 3.290 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8129 - 8129" | |||||||||
| CAEN Financial Year |
8129
|
|||||||||
Comments - Sanipid New Era Srl